As what i've expected earlier in my post that, the take over would likely to go through between HLBANK & EONCAP. HLBANK would likely to offer right issue to raise fund for the acquisition, in my opinion RI for such an exercise is worth taking up for those existing HLBANK shareholders.
**********************************************************************************
KUALA LUMPUR: EON Capital Bhd's board of directors has accepted Hong Leong Bank Bhd's offer to acquire the former's assets and liabilities for a cash consideration of RM5.06bil or RM7.30 per share.
MIMB Investment Bank Bhd said on behalf of the board that this was after taking into consideration Credit Suisse Securities (M) Sdn Bhd's opinion that the offer was not fair from a financial perspective.
Credit Suisse was appointed as the independent adviser for the deal.
MIMB also said EON Capital's board member Ng Wing Fai's views would also be included in a circular to shareholders for the upcoming EGM.
Ng, whose Primus Pacific Partners (HK) Ltd held a 20.2% stake in EON Capital, has expressed disagreement with the board over the offer.
The investment bank said after taking into consideration Credit Suisse's opinion, the advice of the international adviser Goldman Sachs and all relevant aspects of the offer, the board has resolved that the proposed disposal was in the best interest of the bank.
It said the board would table a resolution at the EGM on the proposed disposal as well as the proposed distribution of the cash proceeds to shareholders.
MIMB said the proposed distribution of the cash proceeds arising from the disposal would be done in two parts - a special dividend estimated to be about RM3.30 billion based on EON Capital's audited financial statements as at December 31, 2009 and, a capital reduction exercise amounting to RM1.76bil.
4 comments:
bought some more GENM at 2.72 to further average down holding cost on GENM
Update portfolio + Ultramargin line
1. Kfima 62% (cost: 97.5sen)
2. GENM 60% (cost 2.775)
4. Manulife 27.4% (cost 2.65)
5. PJ devel 19.6% (cost 73sen)
6. Emivest 12% (cost 62sen)
7. Maxis 8.9% (cost 5.25)
7. MWE 8.1% (cost 94.5sen)
8. OKA 5.2% (cost 60.3sen)
Second portfolio + margin line
1. CCM duopharma 40% (cost 2.40)
2. Chuan 16.2% (cost 60.5sen)
3. classic scenic 10% (cost 74.5sen
What is wrong with Kumpulan Fima?
5-year statistics (2006 to projected 2010)
Compounded annual growth rate
Revenue=7%
Operating profit=23%
Net profit=17%
Operating cash flow=43%
Equity=12%
Average ROIC=15%
Dividend yield= 3%
And all these are improving for the last two years, coupled with a very healthy balance sheet. But why Kfima is selling at:
PE=4, price/book=0.65, price/ocf=2?
KC,
Mkt in down trend, any good counter also got bashed down.
Like that provide better value for accumulation, when recover these are the counters will lead its way.
Can accumulate more. :)
Bought maximum GENM at 2.72 to further average down holding cost...
Post a Comment